Best-practice study designs in metabolic research


Focused on:

  • Metabolic Research
  • Obesity Research

Date: 1 June


Time: 2PM London/3PM CET

Selected analytical methods for diabetes and obesity research

According to WHO reports, the prevalence of obesity in EU countries has tripled in the last 30 years, and the number is still rising. Great efforts are being made to correct the underlying dysregulation of energy intake, energy expenditure, and energy storage via new and improved therapeutic approaches. For a better understanding of these dysregulations and their counteracting therapies, the molecular mechanisms need to be studied in more detail. In this webinar we present important and advanced bioanalytical methods to study the metabolic network affected by obesity, comorbidities, and therapy.

We present mass spectrometry-based methods that use isotope labelling techniques to study glucose and lipid kinetics and showcase metabolomics studies that investigated the effect of treatments on the whole intracellular metabolic network. We present a new take on determining total energy expenditure that requires lower sample volumes while providing higher precision analyses. Our portfolio of immunochemical and mass spectrometry-based methods allows us to select the optimal approach for your specific research objective.

The webinar will present a large portfolio of advanced analytical study designs for clinical and preclinical studies in the field of metabolic research. Register if you want to upgrade to the next level of metabolic research.

Presented by

Univ. Prof. Dr. med. Thomas Pieber,

Director Institute HEALTH

Thomas Pieber is Professor of Medicine with more than 450 original papers and reviews in peer-reviewed journals in the fields of diabetes, obesity, endocrinology, metabolism and biomarker research. He is a member of the international Cochrane Review Group “Endocrine and Metabolic Diseases” and serves as reviewer for several journals and funding agencies in EU and USA.

Dr. Christoph Magnes,

Head of Research Group Bioanalytics & Metabolomics

Christoph Magnes' research focus is metabolomics and isotope tracer technologies in metabolic research. He holds a PhD in chemistry and has more than 15 years of experience in mass spectrometry. His laboratory combines high-level research with quality management (GLP certified) to provide analytical services for clinical and preclinical studies.

Dr. Reingard Raml,

Deputy Head of Research Group Bioanalytics & Metabolomics

Reingard Raml is an analytical chemist with experience in various analytical techniques and a focus on mass spectrometry. She has more than 10 years of experience in an interdisciplinary environment to develop analytical methods for medical and pharmaceutical research.

Key Learning Objectives

  • How can analytical methods best support metabolic research?
  • How to quantify peptides that regulate metabolic processes?
  • How to use metabolomics in diabetes and obesity research?
  • How to use stable isotope tracers in clinical studies?


  • Outsourcing manager
  • Head of translational medicine
  • Head of research and development
  • Director
  • Translational Medicine
  • Strategic and Clinical Consulting
  • Vice President research and development
  • Director Medical Affairs
  • Director Clinical Science
  • Director Metabolic Science
  • Chief Development Officer
  • Chief Scientific Officer
  • Head of Development
  • Senior Scientist
  • Associate Professor
  • Vice Executive Director
  • COO
  • CEO
  • CMO
  • Research Coordinator
  • Senior Principal Investigator
  • Principal Investigator